| Antithrombotics |
|
|
|
|
| EPIC - c7E3 (ReoPro) |
|
|
| EPIC - c7E3 (ReoPro) |
|
|
|
|
|
|
|
|
|
|
| Acute Coronary Syndrome |
|
|
| Acute Coronary Syndrome |
|
|
| Low-Molecular-Weight-Heparin (LMWH) |
|
|
| Low-Molecular-Weight-Heparin (LMWH) |
|
|
| LMWH in Acute Coronary Syndrome |
|
|
| LMWH in Acute Coronary Syndrome |
|
|
| Antithrombin Therapy in Acute Coronary Syndrome Antithrombin Therapy in Acute Coronary Syndrome(844k) |
|
|
| Antithrombin Therapy in Acute Coronary Syndrome
 Antithrombin Therapy in Acute Coronary Syndrome(844k) |
|
|
| ESPRIT Study |
|
|
| ESPRIT Study |
|
|
|  CAPRIE Study |
|
|
| Plavix - A New Antiplatelet Agent |
|
|
| CAPRIE Study |
|
|
| Plavix - A New Antiplatelet Agent |
|
|
| Anti-thrombotics and Thrombolytics (1) |
|
|
| Anti-thrombotics and Thrombolytics (2) |
|
|
| Anti-thrombotics and Thrombolytics (1) |
|
|
| Anti-thrombotics and Thrombolytics (2) |
|
|
| FRISC-II: Fragmin and Fast Revascularization During Instablity in Coronary Artery Disease |
|
|
| FRISC-II: Fragmin and Fast Revascularization During Instablity in Coronary Artery Disease |
|
|
Arrhythmia and Pacing |
| Description |
|
|
| CASCADE - Amiodarone in Cardiac Arrest |
|
|
| CAST - Cardiac Arrest Suppression Trial - MI |
|
|
| CHF-STAT - CHF Survival Trial - Post-MI |
|
|
| ESVEM - Electrical Study vs Holter Monitor |
|
|
| ICD - Implantable Cardioverter Defibrillator |
|
|
| SA-ECG - Signal Average ECG |
|
|
| SCD - Sudden Cardiac Death |
|
|
| WCT - Wide-Complex Tachycardia |
|
|
| CASCADE - Amiodarone in Cardiac Arrest |
|
|
| CAST - Cardiac Arrest Suppression Trial - MI |
|
|
| CHF-STAT - CHF Survival Trial - Post-MI |
|
|
| ESVEM - Electrical Study vs Holter Monitor |
|
|
| ICD - Implantable Cardioverter Defibrillator |
|
|
| SA-ECG - Signal Average ECG |
|
|
| SCD - Sudden Cardiac Death |
|
|
| WCT - Wide-Complex Tachycardia |
|
|
| Amiodarone - Preop Prophylaxis for AF |
|
|
| Atrial Fibrillation - Emerging Concepts |
|
|
| Amiodarone - Preop Prophylaxis for AF |
|
|
| Atrial Fibrillation - Emerging Concepts |
|
|
| Amiodarone Post MI - EMIAT and CAMIAT |
|
|
| CAMIAT - Canadian MI Amiodarone Trial |
|
|
| EMIAT - European MI Amiodarone Trial |
|
|
| Amiodarone Post MI - EMIAT and CAMIAT |
|
|
| CAMIAT - Canadian MI Amiodarone Trial |
|
|
| EMIAT - European MI Amiodarone Trial |
|
|
| Postop Arrhythmias - atrial and ventricular |
|
|
| Postop Arrhythmias - atrial and ventricular |
|
|
| Brugada Syndromes |
|
|
| Brugada Syndromes |
|
|
| SCD2 - Sudden Cardiac Death |
|
|
| SCD2 - Sudden Cardiac Death |
|
|
| Ventricular Endocardial Right Bifocal Stimulation |
|
|
| Ventricular Endocardial Right Bifocal Stimulation |
|
|
| Arrhythmia Update - 2001 |
|
|
| Arrhythmias |
|
|
| Arrhythmia Update - 2001 |
|
|
| Arrhythmias |
|
|
| Basic Arrhythmia Analysis and Treatment |
|
|
| Basic Arrhythmia Analysis and Treatment |
|
|
| Cardioversion and Defibrillaiton |
|
|
| Arrhythmias Complicating Acute Myocardial Infarction |
|
|
| Cardioversion and Defibrillaiton |
|
|
| Arrhythmias Complicating Acute Myocardial Infarction |
|
|
Atherosclerosis |
| Description |
|
|
| Antioxidants in Coronary Artery Disease |
|
|
| Antioxidants in Coronary Artery Disease |
|
|
| CAD risk factors - Wizard Trial |
|
|
| CAD risk factors - Wizard Trial |
|
|
| Nitric Oxide - Effects on Endothelial Function (Part 1) |
|
|
| Nitric Oxide - Effects on Endothelial Function (Part 2) |
|
|
| Nitric Oxide - Effects on Endothelial Function (Part 3) |
|
|
| Nitric Oxide - Effects on Endothelial Function (Part 4) |
|
|
| Nitric Oxide - Effects on Endothelial Function (Part 1) |
|
|
| Nitric Oxide - Effects on Endothelial Function (Part 2) |
|
|
| Nitric Oxide - Effects on Endothelial Function (Part 3) |
|
|
| Nitric Oxide - Effects on Endothelial Function (Part 4) |
|
|
Cardiac Imaging |
| Description |
|
|
| Low Dose Dobutamine Detection of Hibernating Myocardium by Tc-99m MIBI Gated SPECT |
|
|
| Low Dose Dobutamine Detection of Hibernating Myocardium by Tc-99m MIBI Gated SPECT |
|
|
| Angiography Atlas |
|
|
| Angiography Atlas |
|
|
Cardiomyopathies and Myocarditis |
| Description |
|
|
| Cardiomyopathies |
|
|
| Myocarditis |
|
|
| Specific Myocardial Diseases |
|
|
| Cardiomyopathies |
|
|
| Myocarditis |
|
|
| Specific Myocardial Diseases |
|
|
| Peripartum Cardiomyopathy |
|
|
| Tachycardia-mediated Cardiomyopathy |
|
|
| Myocarditis |
|
|
| Peripartum Cardiomyopathy |
|
|
| Tachycardia-mediated Cardiomyopathy |
|
|
| Myocarditis |
|
|
| Adriamycin Induced Cardiomyopathy |
|
|
| Adriamycin Induced Cardiomyopathy |
|
|
Drugs in Heart Disease |
| Description |
|
|
| Beta-blockers and the Heart |
|
|
| Calcium-channel blocker update |
|
|
| Beta-blockers and the Heart |
|
|
| Calcium-channel blocker update |
|
|
| Digitalis Intoxication |
|
|
| Digitalis Intoxication |
|
|
Echocardiography |
| Description |
|
|
| Coronary Sinus |
|
|
| Coronary Sinus |
|
|
Electrocardiography |
| Description |
|
|
| Left Ventricular Hypertrophy (LVH) |
|
|
| Left Ventricular Hypertrophy (LVH) |
|
|
Heart Failure |
| Description |
|
|
| AIREX - Ramipril in CHF |
|
|
| AIREX - Ramipril in CHF |
|
|
| ATLAS Trial - Lisinopril in CHF |
|
|
| ATLAS Trial - Lisinopril in CHF |
|
|
| CHF Management - ABCDE's of HF |
|
|
| CHF Management - ABCDE's of HF |
|
|
| Benefits of ACE and AT2 Blockers |
|
|
| Benefits of ACE and AT2 Blockers |
|
|
| RALES |
|
|
| EPHESUS |
|
|
| Aldosterone in Cardiovascular Dysfunction |
|
|
| RALES |
|
|
| EPHESUS |
|
|
| Aldosterone in Cardiovascular Dysfunction |
|
|
| MERIT-HF: A New Paradigm in the Treatment of Heart Failure |
|
|
| MERIT-HF: A New Paradigm in the Treatment of Heart Failure |
|
|
| Chronic Congestive Heart Failure |
|
|
| Chronic Congestive Heart Failure |
|
|
| Biventricular Pacing in Heart Failure |
|
|
| MIRACLE Trial: Biventricular Pacing in Heart Failure |
|
|
| Biventricular Pacing in Heart Failure |
|
|
| MIRACLE Trial: Biventricular Pacing in Heart Failure |
|
|
| Heart Failure 2000 - Expanding Roles of ACE Inhibitors |
|
|
| Success with Failure: Therapeutic Strategies in Heart Failure |
|
|
| Beta Blockers in Heart Failure |
|
|
| Heart Failure 2000 - Expanding Roles of ACE Inhibitors |
|
|
| Success with Failure: Therapeutic Strategies in Heart Failure |
|
|
| Beta Blockers in Heart Failure |
|
|
| Nesiritide in Congestive Heart Failure |
|
|
| Nesiritide in Congestive Heart Failure |
|
|
Hypertension |
| Description |
|
|
| The Sixth Report of the Joint National Committee on the Prevention, Detection, Evaluation and Treatm |
|
|
| The Sixth Report of the Joint National Committee on the Prevention, Detection, Evaluation and Treatm |
|
|
| JNC-VI Editorial |
|
|
| JNC-VI (Official NHLBI Slide Set on Hypertension)) |
|
|
| JNC-VI Editorial |
|
|
| JNC-VI (Official NHLBI Slide Set on Hypertension)) |
|
|
| HOT Trial (Hypertension Optimal Treatment) |
|
|
| HOT Trial (Hypertension Optimal Treatment) |
|
|
| Hypertension in the Emergency Room (Spanish) |
|
|
| Hypertension in the Emergency Room (Spanish) |
|
|
Interventional Cardiology |
| Description |
|
|
| Second-Generation Stents: Equivalence Trials |
|
|
| Second-Generation Stents: Equivalence Trials |
|
|
| In-Stent Restenosis |
|
|
| In-Stent Restenosis |
|
|
| Coronary Stenting |
|
|
| Coronary Stenting |
|
|
| Transmyocardial Revascularization |
|
|
| Transmyocardial Revascularization |
|
|
| Systemic Anaphylactoid Reaction to Intravenous Contrast |
|
|
| Systemic Anaphylactoid Reaction to Intravenous Contrast |
|
|
| Cath Lab Primer - Infection Prevention |
|
|
| Cath Lab Primer - Infection Prevention |
|
|
| In-stent Restenosis |
|
|
| In-stent Restenosis |
|
|
| An Assessment of Restenosis on the Eve of Drug-Eluting Stents |
|
|
Ischemic Heart Disease |
| Description |
|
|
| Estrogen Replacement Therapy and CAD |
|
|
| Estrogen Replacement Therapy and CAD |
|
|
| Heart Disease in Women - HERS Study |
|
|
| Heart Disease in Women - HERS Study |
|
|
| Management of Patients with Chronic Stable Angina |
|
|
| Management of Patients with Chronic Stable Angina |
|
|
| TIMI_IIIA |
|
|
| Unsatble Angina |
|
|
| TIMI_IIIA |
|
|
| Unsatble Angina |
|
|
| Myocardial Ischemia and Infarction |
|
|
| Myocardial Ischemia and Infarction |
|
|
| Coronary Artery Disease in Women |
|
|
| Coronary Artery Disease in Women |
|
|
| Unstable Angina and Non-ST-Segment Elevation Myocaridal Infarction Pocket Guidelines |
|
|
| Unstable Angina and Non-ST-Segment Elevation Myocaridal Infarction Pocket Guidelines |
|
|
| Cardiac Troponin in Renal Insufficiency |
|
|
| Cardiac Troponin in Renal Insufficiency |
|
|
| Acute Coronary Syndrome 2000 (Chinese) |
|
|
| Acute Coronary Syndrome 2000 (Chinese) |
|
|
| Acute Coronary Syndrome 2003 |
|
|
Lipids |
| Description |
|
|
| NCEP Guideline - Key Points |
|
|
| NCEP Guideline - Key Points |
|
|
| Atorvastatin (Lipitor) - information slides |
|
|
| CURVES - comparison study of statin efficacy |
|
|
| Atorvastatin (Lipitor) - information slides |
|
|
| CURVES - comparison study of statin efficacy |
|
|
| Cholesterol Update 1998 |
|
|
| Cholesterol Update 1998 |
|
|
| L-TAP and Treat-to-Target Trial |
|
|
| L-TAP and Treat-to-Target Trial |
|
|
| Atorvastatin - a slide compendium |
|
|
| Atorvastatin - a slide compendium |
|
|
| Cholesterol Update 1999 |
|
|
| Cholesterol Update 1999 |
|
|
| Benefits of Lipid Lowering Therapies |
|
|
| Benefits of Lipid Lowering Therapies |
|
|
| Case Studies in Lipid Management |
|
|
| Case Studies in Lipid Management |
|
|
| Cholesterol Update 2000 |
|
|
| Diabetic Dyslipidemia |
|
|
| Cholesterol Update 2000 |
|
|
| Diabetic Dyslipidemia |
|
|
| C-Reactive Protein for the Targeting of Statin Therapy |
|
|
| C-Reactive Protein for the Targeting of Statin Therapy |
|
|
| MRC/BHF Heart Protection Study |
|
|
| Vascular Biology and Atherosclerosis |
|
|
| ATP III: Identifying and Treating High-Risk Patients |
|
|
| Toward More Aggressive Lipid Lowering Therapy |
|
|
| Vascular Biology and Atherosclerosis |
|
|
| ATP III: Identifying and Treating High-Risk Patients |
|
|
| Toward More Aggressive Lipid Lowering Therapy |
|
|
Miscellaneous |
| Description |
|
|
| The National Service Framework for Coronary Heart Disease in the U.K. |
|
|
| The National Service Framework for Coronary Heart Disease in the U.K. |
|
|
| Clip Art - Cardiopulmonary |
|
|
| Clip Art - Cardiopulmonary |
|
|
Myocardial Infarction |
| Description |
|
|
| Myocardial Injury Markers |
|
|
| Myocardial Injury Markers |
|
|
| Myocardial Infarction |
|
|
| Myocardial Infarction |
|
|
| Management of Acute Myocardial Infarction |
|
|
| Management of Acute Myocardial Infarction |
|
|
| Myocardial Infarction - An Overview |
|
|
| Myocardial Infarction - An Overview |
|
|
| Combination Lytic Therapy in Acute Myocardial Infarction |
|
|
| Combination Lytic Therapy in Acute Myocardial Infarction |
|
|
| Acute Myocardial Infarction - Importance of Time-to-Treatment |
|
|
| Acute Myocardial Infarction - Importance of Time-to-Treatment |
|
|
| Update in the Treatment of Acute Myocardial Infarction |
|
|
| Update in the Treatment of Acute Myocardial Infarction |
|
|
Pericardial Disease |
| Description |
|
|
| Pericardial Disease |
|
|
| Pericardial Disease |
|
|
| Acute Pericarditis |
|
|
| Pericardial Effusion |
|
|
| Cardiac Tamponade |
|
|
| Constrictive Pericarditis |
|
|
| Neoplastic Pericardial Disease |
|
|
| Pericarditis in Renal Failure |
|
|
| Acute Pericarditis |
|
|
| Pericardial Effusion |
|
|
| Cardiac Tamponade |
|
|
| Constrictive Pericarditis |
|
|
| Neoplastic Pericardial Disease |
|
|
| Pericarditis in Renal Failure |
|
|
Peripheral Arterial Disease |
| Description |
|
|
| Vascular Claudication - Diagnosis & Treatment |
|
|
| Vascular Claudication - Diagnosis & Treatment |
|
|
| Medical Treatment of Peripheral Arterial Disease and Claudication |
|
|
| Medical Treatment of Peripheral Arterial Disease and Claudication |
|
|
Preoperative Evaluation |
| Description |
|
|
| ACC/AHA Preoperative Risk Assessment Pocket Guide |
|
|
| ACC/AHA Preoperative Risk Assessment Pocket Guide |
|
|
| ACC/AHA Guideline for Perioperative Cardiac Risk Assessment |
|
|
| ACC/AHA Guideline for Perioperative Cardiac Risk Assessment |
|
|
Sudden Cardiac Death |
| Description |
|
|
| Sudden Cardiac Death in Young Athletes |
|
|
| Sudden Cardiac Death in Young Athletes |
|
|
| Sudden Cardiac Death - Cardiac Resuscitation |
|
|
| Sudden Cardiac Death - Evaluation of |
|
|
| Sudden Cardiac Death - Implantable Defibrillator (ICD) |
|
|
| Sudden Cardiac Death - Cardiac Resuscitation |
|
|
| Sudden Cardiac Death - Evaluation of |
|
|
| Sudden Cardiac Death - Implantable Defibrillator (ICD) |
|
|
Traumatic Heart Disease |
| Description |
|
|
| Traumatic Heart Disease |
|
|
| Traumatic Heart Disease |
|
|
Valvular Heart Disease |
| Description |
|
|
| Aortic Valve Homografts in Adults |
|
|
| Chronic Mitral Regurgitation |
|
|
| Aortic Valve Homografts in Adults |
|
|
| Chronic Mitral Regurgitation |
|
|
| Rheumatic Fever |
|
|
| Rheumatic Fever |
|
|
| Phentermine and Fenfluramine Valvulopathy |
|
|
| Phentermine and Fenfluramine Valvulopathy |
|
|
| Aortic Stenosis |
|
|
| Aortic Stenosis
message:be aware of heart attack and prevent premature death!!!
|
Posts
0 comments:
Post a Comment